Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Generic Active Pharmaceutical Ingredients Industry: Supply and Demand, Markets and Prices 2021-2027

Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Generic Active Pharmaceutical Ingredients Market Status and Forecast (2016-2027)
      • 1.3.2 Global Generic Active Pharmaceutical Ingredients Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Generic Active Pharmaceutical Ingredients Supply by Company

    • 2.1 Global Generic Active Pharmaceutical Ingredients Sales Volume by Company
    • 2.2 Global Generic Active Pharmaceutical Ingredients Sales Value by Company
    • 2.3 Global Generic Active Pharmaceutical Ingredients Price by Company
    • 2.4 Generic Active Pharmaceutical Ingredients Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Generic Active Pharmaceutical Ingredients Market Status by Category

    • 3.1 Generic Active Pharmaceutical Ingredients Category Introduction
      • 3.1.1 Monoclonal Antibodies
      • 3.1.2 Hormones
      • 3.1.3 Cytokines
      • 3.1.4 Fusion Proteins
      • 3.1.5 Therapeutic Enzymes
      • 3.1.6 Vaccines
      • 3.1.7 Blood Factors
    • 3.2 Global Generic Active Pharmaceutical Ingredients Market by Category
      • 3.2.1 Global Generic Active Pharmaceutical Ingredients Sales Volume by Category (2016-2021)
      • 3.2.2 Global Generic Active Pharmaceutical Ingredients Sales Value by Category (2016-2021)
      • 3.2.3 Global Generic Active Pharmaceutical Ingredients Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Generic Active Pharmaceutical Ingredients Market Status by End User/Segment

    • 4.1 Generic Active Pharmaceutical Ingredients Segment by End User/Segment
      • 4.1.1 Oncology
      • 4.1.2 Diabetes
      • 4.1.3 Cardiovascular Disease
      • 4.1.4 CNS and Neurological Disorders
      • 4.1.5 Endocrinology
      • 4.1.6 Others
    • 4.2 Global Generic Active Pharmaceutical Ingredients Market by End User/Segment
      • 4.2.1 Global Generic Active Pharmaceutical Ingredients Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Generic Active Pharmaceutical Ingredients Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Generic Active Pharmaceutical Ingredients Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Generic Active Pharmaceutical Ingredients Market Status by Region

    • 5.1 Global Generic Active Pharmaceutical Ingredients Market by Region
      • 5.1.1 Global Generic Active Pharmaceutical Ingredients Sales Volume by Region
      • 5.1.2 Global Generic Active Pharmaceutical Ingredients Sales Value by Region
    • 5.2 North America Generic Active Pharmaceutical Ingredients Market Status
    • 5.3 Europe Generic Active Pharmaceutical Ingredients Market Status
    • 5.4 Asia Pacific Generic Active Pharmaceutical Ingredients Market Status
    • 5.5 Central & South America Generic Active Pharmaceutical Ingredients Market Status
    • 5.6 Middle East & Africa Generic Active Pharmaceutical Ingredients Market Status

    6 North America Generic Active Pharmaceutical Ingredients Market Status

    • 6.1 North America Generic Active Pharmaceutical Ingredients Market by Country
      • 6.1.1 North America Generic Active Pharmaceutical Ingredients Sales Volume by Country (2016-2021)
      • 6.1.2 North America Generic Active Pharmaceutical Ingredients Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Generic Active Pharmaceutical Ingredients Market Status

    • 7.1 Europe Generic Active Pharmaceutical Ingredients Market by Country
      • 7.1.1 Europe Generic Active Pharmaceutical Ingredients Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Generic Active Pharmaceutical Ingredients Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Generic Active Pharmaceutical Ingredients Market Status

    • 8.1 Asia Pacific Generic Active Pharmaceutical Ingredients Market by Country
      • 8.1.1 Asia Pacific Generic Active Pharmaceutical Ingredients Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Generic Active Pharmaceutical Ingredients Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Generic Active Pharmaceutical Ingredients Market Status

    • 9.1 Central & South America Generic Active Pharmaceutical Ingredients Market by Country
      • 9.1.1 Central & South America Generic Active Pharmaceutical Ingredients Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Generic Active Pharmaceutical Ingredients Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Generic Active Pharmaceutical Ingredients Market Status

    • 10.1 Middle East & Africa Generic Active Pharmaceutical Ingredients Market by Country
      • 10.1.1 Middle East & Africa Generic Active Pharmaceutical Ingredients Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Generic Active Pharmaceutical Ingredients Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Generic Active Pharmaceutical Ingredients Manufacturing Cost Analysis
    • 11.5 Generic Active Pharmaceutical Ingredients Sales Channel and Distributors Analysis
      • 11.5.1 Generic Active Pharmaceutical Ingredients Sales Channel
      • 11.5.2 Generic Active Pharmaceutical Ingredients Distributors
    • 11.6 Generic Active Pharmaceutical Ingredients Downstream Major Buyers

    12 Global Generic Active Pharmaceutical Ingredients Market Forecast by Category and by End User/Segment

    • 12.1 Global Generic Active Pharmaceutical Ingredients Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Generic Active Pharmaceutical Ingredients Forecast by Category
      • 12.2.1 Global Generic Active Pharmaceutical Ingredients Sales Volume Forecast by Category
      • 12.2.2 Global Generic Active Pharmaceutical Ingredients Sales Value Forecast by Category
      • 12.2.3 Global Generic Active Pharmaceutical Ingredients Price Forecast by Category
    • 12.3 Global Generic Active Pharmaceutical Ingredients Forecast by End User/Segment
      • 12.3.1 Global Generic Active Pharmaceutical Ingredients Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Generic Active Pharmaceutical Ingredients Sales Value Forecast by End User/Segment
      • 12.3.3 Global Generic Active Pharmaceutical Ingredients Price Forecast by End User/Segment

    13 Global Generic Active Pharmaceutical Ingredients Market Forecast by Region/Country

    • 13.1 Global Generic Active Pharmaceutical Ingredients Market Forecast by Region (2022-2027)
      • 13.1.1 Global Generic Active Pharmaceutical Ingredients Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Generic Active Pharmaceutical Ingredients Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Teva Pharmaceutical Industries Ltd. (Israel)
      • 14.1.1 Company Information
      • 14.1.2 Generic Active Pharmaceutical Ingredients Product Introduction
      • 14.1.3 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Sanofi (France)
      • 14.2.1 Company Information
      • 14.2.2 Generic Active Pharmaceutical Ingredients Product Introduction
      • 14.2.3 Sanofi (France) Generic Active Pharmaceutical Ingredients Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Pfizer, Inc. (U.S.)
      • 14.3.1 Company Information
      • 14.3.2 Generic Active Pharmaceutical Ingredients Product Introduction
      • 14.3.3 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Novartis International AG (Switzerland)
      • 14.4.1 Company Information
      • 14.4.2 Generic Active Pharmaceutical Ingredients Product Introduction
      • 14.4.3 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Merck & Co., Inc. (U.S.)
      • 14.5.1 Company Information
      • 14.5.2 Generic Active Pharmaceutical Ingredients Product Introduction
      • 14.5.3 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 GlaxoSmithKline plc (U.K.)
      • 14.6.1 Company Information
      • 14.6.2 Generic Active Pharmaceutical Ingredients Product Introduction
      • 14.6.3 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Eli Lilly and Company (U.S.)
      • 14.7.1 Company Information
      • 14.7.2 Generic Active Pharmaceutical Ingredients Product Introduction
      • 14.7.3 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Bristol-Myers Squibb (U.S.)
      • 14.8.1 Company Information
      • 14.8.2 Generic Active Pharmaceutical Ingredients Product Introduction
      • 14.8.3 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Boehringer Ingelheim (Germany)
      • 14.9.1 Company Information
      • 14.9.2 Generic Active Pharmaceutical Ingredients Product Introduction
      • 14.9.3 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 AbbVie Inc. (U.S.)
      • 14.10.1 Company Information
      • 14.10.2 Generic Active Pharmaceutical Ingredients Product Introduction
      • 14.10.3 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Generic Active Pharmaceutical Ingredients market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Generic Active Pharmaceutical Ingredients market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Monoclonal Antibodies
      Hormones
      Cytokines
      Fusion Proteins
      Therapeutic Enzymes
      Vaccines
      Blood Factors

      Segmented by End User/Segment
      Oncology
      Diabetes
      Cardiovascular Disease
      CNS and Neurological Disorders
      Endocrinology
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Teva Pharmaceutical Industries Ltd. (Israel)
      Sanofi (France)
      Pfizer, Inc. (U.S.)
      Novartis International AG (Switzerland)
      Merck & Co., Inc. (U.S.)
      GlaxoSmithKline plc (U.K.)
      Eli Lilly and Company (U.S.)
      Bristol-Myers Squibb (U.S.)
      Boehringer Ingelheim (Germany)
      AbbVie Inc. (U.S.)

      Buy now